Modeling of 3D Structure of Chimeric Constructs Based on Hemagglutinin of Influenza Virus and Immunogenic Epitopes of Streptococcus Agalactiae
- Authors: Fedorova E.A.1, Smolonogina T.A.1, Isakova-Sivak I.N.1, Koren’kov D.A.1, Kotomina T.S.1, Leont’eva G.F.2, Suvorov A.N.2, Rudenko L.G.1
- 
							Affiliations: 
							- A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
- Department of Molecular Microbiology, Institute of Experimental Medicine
 
- Issue: Vol 164, No 6 (2018)
- Pages: 743-748
- Section: Virology
- URL: https://journals.rcsi.science/0007-4888/article/view/239890
- DOI: https://doi.org/10.1007/s10517-018-4071-4
- ID: 239890
Cite item
Abstract
A project of an experimental recombinant vector vaccine for prevention of diseases caused by pathogenic streptococci based on ScaAB lipoprotein of Streptococcus agalactiae and a coldadapted strain of live influenza vaccine as a vector was developed. The sequence of ScaAB lipoprotein was analyzed and fragments forming immunodominant epitopes were determined. Chimeric molecules of influenza virus hemagglutinin H7 carrying insertions of bacterial origin were constructed. Based on the results of simulation, the most promising variants were selected; they represented fragments of lipoprotein ScaAB lacking N-terminal domain bound to hemagglutinin via a flexible linker. These insertions should minimally modulate the properties of the influenza strain, while retaining potential immunogenicity to a wide group of pathogenic streptococci.
About the authors
E. A. Fedorova
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
							Author for correspondence.
							Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
T. A. Smolonogina
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
I. N. Isakova-Sivak
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
D. A. Koren’kov
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
T. S. Kotomina
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
G. F. Leont’eva
Department of Molecular Microbiology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
A. N. Suvorov
Department of Molecular Microbiology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
L. G. Rudenko
A. A. Smorodintsev Department of Virology, Institute of Experimental Medicine
														Email: fedorova.iem@gmail.com
				                					                																			                												                	Russian Federation, 							St. Petersburg						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					